Aikido pharma announces strategic interest in asp isotopes inc.

New york , dec. 6, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced that the company secured a strategic equity interest in asp isotopes, inc., which focuses on the non-nuclear supply of enriched isotopes. asp isotopes' aerodynamic separation process is a method of enriching molybdenum-100 which is a stable isotope of molybdenum.

DOMH Ratings Summary

DOMH Quant Ranking